Longitudinal Patient History Summarization Agent

An agent uses planning and persistent memory to synthesize complex Electronic Medical Record (EMR) data spanning years. It generates a concise, clinically relevant summary for an incoming specialist, highlighting critical trends, past diagnoses, and medication interactions, ensuring consistent care handover.

HealthcareGenerated concept12 chapters

Explore the challenge, proposed system, and assumptions behind this idea. Use the chapters to shape a conversation about what is worth testing.

CONCEPT, FOR REVIEW Generated projections, customer claims, testimonials, and market figures are unverified. Validate sources, feasibility, and commercial assumptions before making decisions.

Discuss this possibility View research Download PDF
Share

Share a concept for discussion.

X / Twitter ↗LinkedIn ↗WhatsApp ↗Email ↗

An idea to evaluate. A clearer next step.
Chapter 1 of 12

Stellitron

Chapter 1 · cover

Intelligent Agentic Memory for Longitudinal Clinical Synthesis

Contact listed in the concept

contact@stellitron.com

Tagline

Powered by Stellitron - Series A Deck

Proposed funding ask

$5,000,000

Proposed value

  • Autonomous EMR Data Synthesis

  • Persistent Clinical Reasoning

  • Specialist-Context Awareness

Explore the concept illustration
Generated illustration for Stellitron
Generated visual reference. Details and text in the illustration may differ from the concept notes.

The Data Overload Crisis

Chapter 2 · problem

Research and impact claims are generated. Source links and confidence labels require independent review.

The challenge

Specialists are drowning in fragmented, multi-year EMR data, spending an average of 20 minutes per patient on manual record reconstruction.

Pain points

  • Physician burnout at record highs due to documentation fatigue

  • Critical diagnostic errors from missed longitudinal trends

  • Inefficient specialist handovers costing health systems millions

Research claim

Label

Avg. time spent per new patient on manual history prep

Value

20 Mins

Source

Clinical Informatics Review 2025

The Stellitron Solution

Chapter 3 · solution

Steps

Desc

Prioritizes data based on specialist type (e.g., Cardiac labs for Cardiologists).

Title

Autonomous Planning

Desc

Maintains clinical reasoning over time, evolving with the patient journey.

Title

Persistent Memory

Description

An AI-native agentic workflow using persistent memory and hierarchical planning to autonomously crawl FHIR-compliant records into context-aware briefs.

Market Opportunity

Chapter 4 · market

Generated commercial assumptions and projections. Independently verify the inputs before using them in an investment or purchasing decision.

Serviceable market

$12.5 Billion (Cloud EMR Specialist Market)

Obtainable market

$850 Million (High-Volume Specialty Clinics)

Total addressable market

$45 Billion (Global Healthcare AI & EMR)

Quote

The shift from generative chat to autonomous clinical agents is the defining trend of 2025.

Competitive Landscape

Chapter 5 · competition

Features

Name

Specialist Planning

Scores
  • Low

  • Low

  • High

Name

Persistent Memory

Scores
  • Low

  • Medium

  • High

Name

EHR Integration

Scores
  • High

  • High

  • High

Competitors

  • Particle Health

  • Abridge

  • Stellitron

Business Model

Chapter 6 · business model

Generated commercial assumptions and projections. Independently verify the inputs before using them in an investment or purchasing decision.

Streams

Desc

Annual recurring revenue based on seat count and specialty modules.

Title

B2B SaaS Subscription

Value

$15k - $50k / clinic

Desc

Volume-based pricing for high-throughput academic medical centers.

Title

Usage-Based Processing

Value

$1.50 / summary

Desc

Implementation and private API bridge setup for large health systems.

Title

Enterprise Integration

Value

$100k+ / one-time

Traction & Validation

Chapter 7 · traction

Unverified generated claims. Pilot, customer, testimonial, and performance statements shown here are not established evidence of Stellitron’s work.

Metrics

Label

Beta Completion

Value

Q4 2025

Label

Pilot Expansion

Value

Q1 2026

Label

LTV/CAC

Value

11.25x

Unverified testimonial

Stellitron has reduced our pre-visit prep time by 70%, allowing our specialists to focus entirely on the patient.

Financial Projections

Chapter 8 · financials

Generated commercial assumptions and projections. Independently verify the inputs before using them in an investment or purchasing decision.

Projected indicators

LTV / CAC

11.25x

Year 5 EBITDA

32%

CAC payback

11 Months

Revenue projections

Year

Y1

Revenue

450k

Year

Y2

Revenue

2.2M

Year

Y3

Revenue

7.5M

Year

Y4

Revenue

18.0M

Year

Y5

Revenue

42.5M

The Ask

Chapter 9 · ask

Generated commercial assumptions and projections. Independently verify the inputs before using them in an investment or purchasing decision.

Round

Series A

Amount

$5,000,000

Runway

24 Months

Allocation

GTM & Sales

20%

Ops & Legal

10%

Clinical & Regulatory

20%

Engineering & Product

50%

Exit Strategy

Chapter 10 · exit

Generated commercial assumptions and projections. Independently verify the inputs before using them in an investment or purchasing decision.

Scenarios

Type

Health System Acquisition

Timeframe

7-9 years

Valuation

$550M

Probability

Strategic Fit

Potential Acquirers
  • UnitedHealth Group

  • CVS Health

Type

EHR Vendor Integration

Timeframe

5-7 years

Valuation

$340M

Probability

High Probability

Type

AI Consolidation

Timeframe

4-6 years

Valuation

$212M

Probability

Medium Probability

Comparable Exits

Year

2025

Company

Abridge (Valuation)

Exit Type

Funding/Valuation

Exit Value

$5.3B

Risk Analysis

Chapter 11 · risks

Risks

Risk

LLM Hallucinations in Clinical Summaries

Category

Technical

Mitigation

Human-in-the-loop UI and RAG architecture for source-linked citations.

Risk

Incumbent EMR Disintermediation

Category

Market

Mitigation

Deep integration hooks and focus on cross-institutional data portability.

Risk

FDA SaMD Classification

Category

Regulatory

Mitigation

Positioned as Clinical Decision Support (CDS) to remain Class I.

Sources & References

Chapter 12 · sources

Contact listed in the concept

contact@stellitron.com

Sources

Type

Market Analysis

Title

CVS Health's AI Strategy Dominance

Type

Funding Data

Title

Abridge $5.3B Valuation Report

Type

Industry Report

Title

AI in EHR: Benefits & Costs 2025

Disclaimer

This pitch deck is AI-generated for illustrative purposes. All financial projections and market data are estimates and should be validated with professional advisors.

Data sources

  • Exa AI Web Search

  • ArXiv Healthcare Agent Orchestrator Research

  • Stellitron Internal Financial Models

Generated by

Stellitron AI

When a chapter is focused, use ← and → to move between chapters. Home and End jump to the first and last chapter.

What would this need
to work in your world?

Start with the workflow, the people who review it, and the evidence a pilot should produce.

Explore a workflow Talk through a pilot ↗

Context for your review

Generated assumptions
  • Tiered pricing model based on patient volume with an average ACV of $45,000
  • Sales cycle of 6-9 months for mid-market health systems
  • Market penetration reaching 5% of SOM by Year 5
  • Expansion revenue from existing accounts via additional clinical departments
Listed research sources
  • AI Market Research
  • Competitive Intelligence
  • Financial Modeling

Source listings have not been independently verified by this viewer.

This pitch deck is AI-generated for illustrative purposes. All financial projections, valuations, and market data are estimates and should be validated with professional advisors.

Longitudinal Patient History Summarization Agent — Generated Concept | Stellitron Technologies